肝硬化湿热瘀毒郁结复合病机的理论及临床应用研究
Scientific Connotation and Clinical Application of the Compound Pathogenesis of Hepatocirrhosis Characterized by Constraint of Dampness-Heat and Stasis-Toxin
-
摘要: 探讨了肝硬化湿热瘀毒郁结复合病机理论的科学内涵与临床应用,认为湿热瘀毒复合病机是肝硬化进程演化中的核心病机,瘀热是肝硬化湿热瘀毒郁结复合病机中的关键环节。并对肝硬化湿热瘀毒郁结复合病机的现代医学病理生物学基础进行了探讨,提出了清化湿热瘀毒法辨治肝炎-肝纤维化-肝硬化的临床思路,揭示了清化湿热瘀毒法对肝硬化形成和加重过程中免疫及炎症反应网络的多环节调控作用机理,为中医病机理论的创新研究提供示范。Abstract: The paper discussed the scientific connotation and clinical application of the compound pathogenesis of hepatocirrhosis characterized by constraint of dampness-heat and stasis-toxin. Constraint of dampness-heat and stasis-toxin was regarded as the core pathogenesis, and stasis-heat was the key link. Besides, we explored the patho-biological basis of the compound pathogenesis in modern medicine, proposed the clinical thought of clearing and removing dampness-heat and stasis-toxin, disclosed the mechanisms of regulating immune and inflammatory symptomatic response network during the progress of hepatocirrhosis with clearing and removing therapy, and provided a demonstration for the innovative research of the pathogenesis theory in traditional Chinese medicine.
-
[1] 张仕玉,镇东鑫,刘子彬.姜春华教授治疗肝硬化经验[J].中国中医急症,2008,17(10):1412,1430. [2] 俞广声,唐民圭,阮望春,等.桃仁治疗血吸虫病性肝硬化的研究 [J].中医杂志,1986,27(6): 24-25. [3] 李琼,滕龙,李永勤,等.周信有辨治病毒性肝硬化经验[J].中医杂志,2018,59(8): 643-645. [4] 李宗平,杨建香.早期乙型肝炎肝硬化治疗思路探析[J].辽宁中医药大学学报,2007,9(6):25-26. [5] 徐列明.肝纤维化或肝硬化“正虚血瘀”中医病机的临床观察和研究[J].世界科学技术-中医药现代化,2016,18(9): 1465-1470. [6] 周学平,叶放,郭立中,等.中医病机辨证新体系的构建[J].南京中医药大学学报,2016,32(4): 301-304. [7] 叶放,薛博瑜,周珉,等.论湿热瘀毒与肝纤维化[J].南京中医药大学学报,2005,21(6):346-349. [8] 叶放,周学平,周仲瑛.复合病机转化论初探[J].中医杂志,2010,51(10): 869-871,874. [9] 张志聪.黄帝内经素问集注[M].上海:上海科学技术出版社,1959:11-12. [10] 张志聪.黄帝内经灵枢集注[M]//郑林.张志聪医学全书.北京:中国中医药出版社,1999:578-580. [11] 叶放,薛博瑜,吴勉华,等.重视对慢性肝炎肝纤维化进程中湿热瘀毒证治研究[J].中华中医药学刊,2007,25(12): 2477-2480. [12] 肖莉,郭军,叶放.国医大师周仲瑛教授对753例慢性肝炎病机辨识经验研究 [J].中华中医药学刊,2014,32(10): 2461-2465. [13] 王佳赢.慢性肝病不同病程阶段病机证素分布特点临床调查研究[D].南京:南京中医药大学,2012. [14] 叶放,徐吉敏,薛博瑜,等.慢性肝炎“湿热瘀毒互结”复合病机的形成机制探讨 [J].中医杂志,2011,52(22): 1908-1910. [15] 张华,王磊,苏越,等.基于偏最小二乘法的中医临床肝炎肝硬化主、次证候分类特征研究 [J].世界中医药,2014,9(5): 541-544,548. [16] SEO YS, SHAH VH. The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension[J]. Clin Mol Hepatol, 2012, 18(4): 337-346. [17] 〖JP3〗WIEST R, LAWSON M, GEUKING M. Pathological bacterial translocation in liver cirrhosis[J]. J Hepatol, 2014, 60(1):197-209.〖JP〗 [18] ZHU Q, ZOU L, JAGAVELU K, et al. Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice [J]. J Hepatol, 2012, 56(4): 893-899. [19] SHI H, DONG L, DANG X, et al. Effect of chlorogenic acid on LPS-induced proinflammatory signaling in hepatic stellate cells [J]. Inflamm Res, 2013, 62(6): 581-587. [20] DING BS, CAO Z, LIS R, et al. Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis [J]. Nature, 2014, 505(7481): 97-102.
点击查看大图
计量
- 文章访问数: 476
- HTML全文浏览量: 8
- PDF下载量: 517
- 被引次数: 0